Tag ~drug development

Tag descriptions coming soon to Wherrelz News!


As researchers pursue links between bacteria and human health startups stand to benefit

Aduhelm approval sparks HHS watchdog review of FDAs accelerated approval pathway

Quris combines AI with patient on a chip to speed drug development and reduce animal testing

Cradles AIpowered protein programming platform levels up with 24M in new funding

Ohiobased collaboration service for biotech and pharma research Within3 raises 100 million

C2i a genomics SaaS product to detect traces of cancer raises 100M Series B

Stem cell startup Silene Biotech acquired by NanoSurface Biomedical in allSeattle deal

Mammoth Biosciences adds the final piece of the CRISPR diagnostics puzzle to its toolkit

Groupon cofounder Eric Lefkofsky just raised another 200 million for his newest company Tempus

Resilience raises over 800 million to transform pharmaceutical manufacturing in response to COVID19

Generate Biomedicines raises 370M Series B with a focus on proteinbased drugs

Atomwises machine learningbased drug discovery service raises 123 million

How can you understand life if you dont look at it live Eikon Therapeutics rakes in 518M

Famed founder Daphne Koller tells it straight: With most drugs we do not understand why they work

5 investors explain why longevity tech is a longterm play

Neurobehavioral health company Blackthorn pulls in 76 million from GV to treat mental disorders

Longevity startup Gero AI has a mobile API for quantifying health changes

Bit Bios enter button for the keyboard to the software of life nabs the company 415 million

Fred Hutch spinout SEngine raises 51M to test cancer treatment drugs against a patients tumors

Implantable 3D printed organs could be coming sooner than you think

African genomics startup 54gene raises 15M led by Adjuvant Capital

Implantable 3Dprinted organs could be coming sooner than you think

Bioprinting for Burns and Cancer on the Horizon for CTI Biotech

Exclusive Interview: BICOs New Bioprinting Era under Maria Forss Begins

6 questions investors should ask when evaluating psychedelic biotech companies

TinyML is giving hardware new life

Manifold Bios molecular barcodes could break through pharmas in vivo bottleneck

Weed in space is going to be a thing now

Shares of protein discovery platform Absci pop in market debut

How Cerebral and Alto Neuroscience embarked on an athome clinical trial for depression

Emerging from stealth Octant is bringing the tools of synthetic biology to large scale drug discovery

Vinehealth offering digital support for cancer patients and SaaS for RD gets 55M to launch in the US

On the heels of a 40 million round TriNetX brings its services for drug trials to Europe

How one company is fasttracking development of potential plasmabased treatments for the coronavirus